AHLA

Skip to Main Content

March 15, 2024

Health Law Weekly

Featured Articles

A Look at Distressed Health Care Transactions

Embryonic Personhood and Scientific Research Following the Alabama Supreme Court Decision on In Vitro Fertilization

The Governance Implications of DOJ’s New Corporate Fraud Enforcement Guidance

Top Ten 2024: Drug Pricing—340B Developments to Watch

Current Topics

Fraud and Compliance

Father and Son Sentenced to Prison for Medicare DME Scheme

Government Intervenes in Whistleblower Suit Alleging Six Health Plans, Trade Group Concealed Overpayments for Military Health Care Program

Home Health Care Agency, Owner Agree to $600,000 Settlement of False Billing Allegations

Physician Agrees to $95,000 Settlement of Genetic Testing Fraud Allegations

Physician Handed Prison Time for Unlawful Drug Distribution, COVID-19 Relief Program Fraud

Second Circuit Revives Whistleblower’s State FCA Claims Against McKesson

Sleep Clinic Owner Sentenced to 19 Months in Prison for Medicare Fraud

Supplement Company Owner Pleads Guilty to Falsely Marketing Products as COVID-19 Treatments

Telemedicine, DME Company Owner Pleads Guilty to $136 Million Medicare Fraud Conspiracy

Health Care Finance and Transactions

AstraZeneca to Buy Biotech Amolyt for $1.5 Billion

Health Information

OCR Announces Change Healthcare Cyberattack Probe

Health Policy and Administration

Administration’s FY 2025 Budget Request Looks to Lower Drug Costs, Expand Behavioral Health Access

Life Sciences

Eighth Circuit Upholds Arkansas Law Protecting Use of Contract Pharmacies for 340B Drugs

Patient Care Liability and Litigation

Complaints Allege Faulty Medicaid Renewal Practices of DC, Texas Violate ADA

U.S. Court in Oklahoma Says Hospital Conducted Adequate EMTALA Screening

Current Issue

Health Law Weekly Issue - March 15, 2024